GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimers disease
The drugs have different molecular structures, binding affinities, pharmacokinetic profiles, and (in the case of tirzepatide) entirely different receptor targets
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, et al
The ASD-related nosological entities are many, yet they all seem to reflect an abnormal development of the CNS in pre- and early postnatal periods, linked to either genetic heritage or environmental insults
For several years, 503A and 503B compounding pharmacies produced peptides like BPC-157 in what we call a regulatory gray zone
RL: Data curation, Formal analysis, Investigation, Methodology, Writing review & editing